Search Publications


per page

Found 281 matches. Displaying 1-10 Toggle highlighting of searched terms

[ 1-10 | Next ]

1. Papp KA, Reich K, Paul C, Blauvelt A, Baran W, Bolduc C, Toth D, Langley RG, Cather J, Gottlieb AB, Thaci D, Krueger JG, Russell CB, Milmont CE, Li J, Klekotka PA, Kricorian G, Nirula A   A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis   BRITISH JOURNAL OF DERMATOLOGY 2016 AUG; 175(2):273-286 Full Text | PMID/PMCID

2. Brunner PM, Khattri S, Garcet S, Finney R, Oliva M, Dutt R, Fuentes-Duculan J, Zheng XZ, Li X, Bonifacio KM, Kunjravia N, Coats I, Cueto I, Gilleaudeau P, Sullivan-Whalen M, Suarez-Farinas M, Krueger JG, Guttman-Yassky E   A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2016 JUL; 138(1):169-178 Full Text | PMID/PMCID

3. Gulati N, Carvajal RD, Postow MA, Wolchok JD, Krueger JG   Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment   EXPERIMENTAL DERMATOLOGY 2016 JUL; 25(7):553-554 Full Text | PMID/PMCID

4. Czarnowicki T, Krueger JG, Guttman-Yassky E   Systemic B-cell abnormalities in patients with atopic dermatitis? Reply   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2016 JUL; 138(1):318-320 Full Text | PMID/PMCID

5. Krueger JG, Kircik L, Hougeir F, Friedman A, You XJ, Lucas N, Greenberg SJ, Sweetser M, Castro-Borrero W, McCroskery P, Elkins J   Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis   ADVANCES IN THERAPY 2016 JUL; 33(7):1231-1245 Full Text | PMID/PMCID

6. Goldminz AM, Suarez-Farinas M, Wang AC, Dumont N, Krueger JG, Gottlieb AB   Methotrexate improves pro- and anti-atherogenic genomic expression in psoriatic skin   JOURNAL OF DERMATOLOGICAL SCIENCE 2016 JUN; 82(3):207-209 Full Text | PMID/PMCID

7. Harden JL, Lewis SM, Lish SR, Suarez-Farinas M, Gareau D, Lentini T, Johnson-Huang LM, Krueger JG, Lowes MA   The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2016 JUN; 137(6):1830-1840 Full Text | PMID/PMCID

8. Papp KA, Krueger JG, Feldman SR, Langley RG, Thaci D, Torii H, Tyring S, Wolk R, Gardner A, Mebus C, Tan HM, Luo YC, Gupta P, Mallbris L, Tatulych S   Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 2016 MAY; 74(5):841-850 Full Text | PMID/PMCID

9. Bissonnette R, Suarez-Farinas M, Li X, Bonifacio KM, Brodmerkel C, Fuentes-Duculan J, Krueger JG   Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris   PLOS ONE 2016 MAY 6; 11(5):? Article e0155215 Full Text | PMID/PMCID

10. Ritchlin CT, Krueger JG   New therapies for psoriasis and psoriatic arthritis   CURRENT OPINION IN RHEUMATOLOGY 2016 MAY; 28(3):204-210 Full Text | PMID/PMCID

[ 1-10 | Next ]